U

Universal Vision Biotechnology Co Ltd
TPEX:3218

Watchlist Manager
Universal Vision Biotechnology Co Ltd
TPEX:3218
Watchlist
Price: 136.5 TWD -4.21% Market Closed
Market Cap: NT$11.6B

Wall St Price Targets

Price Targets Summary
Universal Vision Biotechnology Co Ltd

Wall Street analysts forecast Universal Vision Biotechnology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Universal Vision Biotechnology Co Ltd is 155.55 TWD with a low forecast of 151.5 TWD and a high forecast of 162.75 TWD.

Lowest Forecast
Price Target
151.5 TWD
11% Upside
Average Forecast
Price Target
155.55 TWD
14% Upside
Highest Forecast
Price Target
162.75 TWD
19% Upside
Universal Vision Biotechnology Co Ltd Competitors:
Price Targets
PHVS
Pharvaris NV
33% Upside
VNET
Vianet Group PLC
222% Upside
YUMC
Yum China Holdings Inc
33% Upside

Revenue
Forecast

14% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
14% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 2 years is 4%.

Gross Profit
Forecast

17% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
17% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 1 year is 5%.

Operating Income
Forecast

N/A
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Operating Income over the next 2 years is 4%.

Pre-Tax Income
Forecast

N/A
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 2 years is 6%.

Net Income
Forecast

N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Net Income over the next 2 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Universal Vision Biotechnology Co Ltd's stock price target?
Price Target
155.55 TWD

According to Wall Street analysts, the average 1-year price target for Universal Vision Biotechnology Co Ltd is 155.55 TWD with a low forecast of 151.5 TWD and a high forecast of 162.75 TWD.

What is the Revenue forecast for Universal Vision Biotechnology Co Ltd?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 2 years is 4%.

What is the Gross Profit forecast for Universal Vision Biotechnology Co Ltd?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 1 year is 5%.

What is the Operating Income forecast for Universal Vision Biotechnology Co Ltd?
Projected CAGR
4%

The compound annual growth rate for Operating Income over the next 2 years is 4%.

What is the Pre-Tax Income forecast for Universal Vision Biotechnology Co Ltd?
Projected CAGR
6%

The compound annual growth rate for Pre-Tax Income over the next 2 years is 6%.

What is the Net Income forecast for Universal Vision Biotechnology Co Ltd?
Projected CAGR
9%

The compound annual growth rate for Net Income over the next 2 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett